Notícias e Atividades da PMV Pharmaceuticals

PMV Pharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

PMV Pharmaceuticals é uma empresa listada sob o símbolo PMVP (US).

Veja o organograma con seus 18 executivos principais

Biografias mais buscadas da PMV Pharmaceuticals

• David Mack, Director, President and Chief Executive Officer
• Laurie Stelzer, Director
• Charles Baum, Director

Criar um alerta
para seguir os movimentos de executivos da PMV Pharmaceuticals.

PMV Pharmaceuticals possui 1.824 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Roche (Suíça).

Popular M&A news in Farmacêutica

• Cyclo Therapeutics adquiriu Rafael Holdings (publicado em 28 de abril de 2025).
• Chimerix and Chimerix have merged  (publicado em 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Jean-Michel Demeure - Vice President, Finance Global Operations da Sanofi
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de PMV Pharmaceuticals

• PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
• PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
• PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
• View more press releases Close

Redes sociais sobre PMV Pharmaceuticals

• PMV Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• PMV Pharmaceuticals na LinkedIn, Twitter e YouTube